Developing neuroprotective drugs for glaucoma no easy task


Neuroprotection is a concept that originated in the CNS community with the development of therapies aimed at preventing or retarding the manifestations of disorders such as Parkinson's and Alzheimer's diseases, stroke, and head trauma. Less than 15 years ago, the ophthalmic community began to discuss this concept as a novel way to preserve vision in disorders of the retina.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.